Durata Therapeutics (DRTX) – Corporate News
-
Durata Therapeutics (DRTX) Receives Positive CHMP Opinion on Xydalba as ABSSSI Treatment
-
Durata Therapeutics (DRTX) Presents New Data for DALVANCE
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DRTX Stock Lookup